Related Experiment Videos
Professional considerations for providing mifepristone-induced abortion
S L Fielding1, S S Lee, E A Schaff
1Reproductive Health Program, University of Rochester, Rochester, N.Y., USA.
The Nurse Practitioner
|January 5, 2002
Summary
Primary care providers can now offer mifepristone for medical abortion. This guide covers pharmacology, clinical considerations, and managing potential complications for mifepristone and misoprostol.
Area of Science:
- Reproductive Health
- Pharmacology
Background:
- Mifepristone (Mifeprex) is now available as an abortifacient option for primary care.
- Clinicians must navigate state regulations, zoning, staffing, and reimbursement.
Purpose of the Study:
- To inform primary care clinicians about offering mifepristone for medical abortion.
- To discuss the pharmacology, clinical considerations, and management of adverse effects.
Main Methods:
- Review of mifepristone and misoprostol pharmacology.
- Discussion of clinical practice considerations.
- Guidance on preventing and managing adverse effects and complications.
Main Results:
- Primary care clinicians can prescribe mifepristone for medical abortion.
- Successful implementation requires understanding state laws and logistical factors.
- Effective management of potential complications is crucial.
Conclusions:
- Mifepristone offers a new option for medical abortion in primary care settings.
- Clinicians need to be aware of regulatory, logistical, and clinical management aspects.
- Comprehensive patient care includes managing potential adverse effects.